Viewing nowGlimepiride 3mg Tablet
Glimepiride 3mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

MFDS item code 200801332 · Notified 2008.01.31 · Insurance code 642505050
Improves blood glucose control in type 2 diabetes mellitus
This medicine is used to enhance blood sugar control in patients with type 2 diabetes, as an adjunct to dietary and exercise regimens. It can be administered as monotherapy, and in cases where adequate blood sugar control is not achieved with oral hypoglycemic agents, it can be used in conjunction with insulin. Furthermore, it may be combined with metformin if monotherapy with sulfonylureas or metformin is ineffective. This medicine is useful in aiding diabetes management by improving blood sugar levels.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received drug therapy, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional effect with doses above 4 mg, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the patient's requirement for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose-equivalence relationship between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the method described under Initial dose. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the efficacy and duration of action of the previous medication. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by taking sugar. Hypoglycemia may recur despite initially successful management during treatment with sulfonylureas. Therefore, patients should be monitored closely. Severe hypoglycemia requires immediate medical treatment and follow-up, and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate caution should be exercised.
This medicine should not be used in patients with insulin-dependent diabetes or severe hepatic or renal impairment. Additionally, pregnant or nursing women should not take this medicine. During the first week of treatment, there is a high risk of hypoglycemia, so blood sugar levels should be closely monitored, and caution is required in cases of poor nutritional status, skipping meals, elderly patients, patients with impaired renal or liver function, and those taking other medications. This medicine can cause hypoglycemia, and symptoms of hypoglycemia may include headache, fatigue, anxiety, dizziness, and in severe cases, coma, so immediate intake of sugar is necessary if symptoms of hypoglycemia occur. Additionally, rare occurrences of liver dysfunction, blood disorders, and allergic reactions may happen, so if any abnormal symptoms occur, consult a doctor immediately. It is important to take this medicine regularly while adhering to dietary and exercise routines, and patients must be adequately informed about the methods and risks of managing hypoglycemia. Since this medicine may interact with other medications, new medications should be reported to a healthcare professional when starting or stopping their use, and caution should be taken as alcohol consumption may affect blood sugar control. In cases of overdose, severe hypoglycemia can occur, so immediate visit to a hospital for appropriate treatment is necessary, and it should be kept out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly sealed container to protect it from air and moisture. The recommended storage temperature is between 1 and 30 degrees Celsius.
This medicine is a yellow, oblong tablet.
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 3mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.